RSNA: Weight Loss Via Exercise Alone Not Protective for Knees

This article originally appeared here.
Share this content:
RSNA: Weight Loss Via Exercise Alone Not Protective for Knees
RSNA: Weight Loss Via Exercise Alone Not Protective for Knees

THURSDAY, Nov. 30, 2017 (HealthDay News) -- For obese and overweight individuals, weight loss through diet and diet and exercise (but not exercise alone) is associated with slowing of cartilage degeneration, according to a study presented at the annual meeting of the Radiological Society of North America, held from Nov. 26 to Dec. 1 in Chicago.

Alexandra S. Gersing, M.D., from the University of California San Francisco, and colleagues examined cartilage biochemical degeneration and morphologic joint abnormalities over 96 months in 380 overweight and obese subjects losing weight (>5 percent of baseline body mass index; categorized as diet and exercise, diet only, and exercise only) and frequency matched to 380 controls with stable weight.

The researchers found that, compared with controls, the weight loss group had significantly lower progression of cartilage Whole-Organ Magnetic Resonance Imaging Scores over 96 months (P < 0.001). Significantly less T2-value increase was seen in the bone layer of all compartments for subjects with weight loss versus controls (P < 0.03 for each). Compared with the stable weight group, the diet and diet and exercise groups had the lowest rates of increase in cartilage T2 averaged over all compartments (P = 0.042 and 0.003, respectively). Compared to subjects with stable weight, there was no significant difference in change of T2 over 96 months for the weight loss through exercise alone group (P = 0.56).

"Results suggest that cartilage degeneration is slowed through weight loss in obese and overweight subjects over 96 months," the authors write. "This protective effect was, however, only found in subjects losing weight through diet and combined exercise and diet programs."

Abstract
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »